Holen Sie sich die Stockscreener-App
53.98
0.55%
-0.30
Handel nachbörslich:
53.98
Vaxcyte Inc Aktie (PCVX) Neueste Nachrichten
Insider Sell: Elvia Cowan Sells 1,892 Shares of Vaxcyte Inc (PCVX) - GuruFocus
Insider Sell: Elvia Cowan Sells 1,892 Shares of Vaxcyte Inc (PCV - GuruFocus
Vaxcyte publishes VAX-31 phase 1/2 study results in Lancet By Investing.com - Investing.com South Africa
Vaxcyte (PCVX) Advances VAX-31 Vaccine with Positive Study Resul - GuruFocus
Vaxcyte (NASDAQ:PCVX) CAO Sells $105,138.44 in Stock - MarketBeat
Vaxcyte (PCVX) Price Target Decreased by 17.52% to 83.49 - MSN
Vaxcyte : March Investor Presentation (6862ba) - marketscreener.com
Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate - The Manila Times
Vaxcyte publishes VAX-31 phase 1/2 study results in Lancet - Investing.com UK
Vaxcyte Advances VAX-31 into Phase 3 Clinical Program Following Positive Phase 1/2 Study Results in Older Adults - Quiver Quantitative
Vaxcyte publishes positive Vax-31 phase 1/2 adult study results in The Lancet Infectious Diseases - marketscreener.com
A 31-strain pneumonia shot showed strong immune responses in adults 50+ - Stock Titan
Vaxcyte SVP, finance & CAO Cowan sells $105k in stock - Investing.com India
Vaxcyte Publishes Positive Vax-31 Phase 1/2 Adult Study Results In The Lancet Infectious Diseases - TradingView
Positive VAX-31 Phase 1/2 Adult Data Published in The - GlobeNewswire
Vaxcyte (PCVX) finance SVP sells 1,892 shares under 10b5-1 plan - Stock Titan
Vaxcyte Completes $632.5 Million Public Offering of Common Stock - Global Legal Chronicle
Elvia Cowan sells shares; RSU vesting at PCVX (NASDAQ: PCVX) - Stock Titan
Forecast Cut: Is Vaxcyte Inc affected by consumer sentimentPortfolio Return Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
Vaxcyte, Inc. $PCVX Shares Sold by Aquatic Capital Management LLC - MarketBeat
HighVista Strategies LLC Acquires 53,345 Shares of Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte, Inc. $PCVX Shares Acquired by Boothbay Fund Management LLC - MarketBeat
PCVX Technical Analysis & Stock Price Forecast - Intellectia AI
Vaxcyte to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on February 24, 2026 - Quantisnow
Love a little risk? Wall Street sees massive upside in Vaxcyte stock - MSN
Pivotal bioVenture Partners Boosts Stake in Vaxcyte - National Today
Pivotal bioVenture Partners Investment Advisor LLC Raises Stock Position in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte Inc Stock (ISIN: US92242T1016) Slides on Major Investor Stake Cut - AD HOC NEWS
Vaxcyte Shares Decline as Capital Research Global Investors Reduces Stake - National Today
Vaxcyte, Inc. $PCVX Holdings Lowered by Capital Research Global Investors - MarketBeat
Victory Capital Management Inc. Lowers Stock Holdings in Vaxcyte, Inc. $PCVX - MarketBeat
Aug PostEarnings: Can Vaxcyte Inc continue delivering strong returnsQuarterly Market Review & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Vaxcyte (NASDAQ:PCVX) CAO Elvia Cowan Sells 2,500 Shares - MarketBeat
Vaxcyte (PCVX) officer surrenders shares to cover RSU taxes - Stock Titan
Vaxcyte (PCVX) CEO surrenders 3,685 shares to cover RSU taxes - Stock Titan
Vaxcyte (PCVX) CFO uses 1,021 shares to cover RSU tax withholding - Stock Titan
Vaxcyte (PCVX) finance SVP exercises options and sells 2,500 shares - Stock Titan
Vaxcyte (PCVX) COO logs planned stock sales and RSU tax withholding - Stock Titan
Jefferies reiterates Vaxcyte stock Buy rating on regulatory clarity By Investing.com - Investing.com South Africa
Jefferies Maintains Buy on Vaxcyte (PCVX) March 10, 2026 - Meyka
PCVX (NASDAQ: PCVX) Form 144: insider notice to sell RSU shares - Stock Titan
Jefferies reiterates Vaxcyte stock Buy rating on regulatory clarity - Investing.com UK
Understanding the Setup: (PCVX) and Scalable Risk - Stock Traders Daily
Vaxcyte’s Heavy Equity Raise and Wider Losses Could Be A Game Changer For Vaxcyte (PCVX) - simplywall.st
Neo Ivy Capital Management Has $2.99 Million Stock Position in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
BTIG Reiterates Vaxcyte (PCVX) Buy Recommendation - MSN
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vaxcyte (PCVX), Universal Health (UHS) and MoonLake Immunotherapeutics (MLTX) - The Globe and Mail
Vaxcyte (PCVX) CFO awarded RSUs and options, surrenders shares for taxes - Stock Titan
Vaxcyte (NASDAQ: PCVX) SVP granted options, RSUs and surrenders shares for taxes - Stock Titan
Vaxcyte Earnings Call: Cash Strength, Trials Accelerate - TipRanks
Does Heavy 2025 Loss and Large Equity Raise for Vaxcyte’s VAX-31 Shift the Bull Case (PCVX)? - Yahoo Finance
Love A Little Risk? Wall Street Sees Massive Upside in Vaxcyte Stock. - Yahoo Finance
Vaxcyte, Inc. (PCVX) - DirectorsTalk Interviews
Vaxcyte, Inc. $PCVX Shares Sold by TD Asset Management Inc - MarketBeat
Vaxcyte Advances VAX-31 Toward Phase 3 As Valuation Gap Persists - Yahoo Finance
A Look At Vaxcyte (PCVX) Valuation As Share Price Momentum Rebuilds - Yahoo Finance
Vaxcyte (PCVX) Is Up 5.5% After Unveiling VAX-31 Data, Phase 3 Plans And New FinancingHas The Bull Case Changed? - simplywall.st
Citigroup Inc. Sells 116,206 Shares of Vaxcyte, Inc. $PCVX - MarketBeat
PCVX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Assessing Vaxcyte (PCVX) Valuation After Recent Share Price Volatility - simplywall.st
Analysts’ Top Healthcare Picks: Vaxcyte (PCVX), TransMedics Group (TMDX) - The Globe and Mail
Westfield Capital Management Co. LP Purchases 663,817 Shares of Vaxcyte, Inc. $PCVX - MarketBeat
Vanguard Group Inc. Has $443.78 Million Holdings in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte (PCVX): BTIG Raises Price Target, Maintains Buy Rating | - GuruFocus
1.20%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):